|
|
|
Volumn 37, Issue 5, 2002, Pages 271-273
|
|
Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANDROSTENEDIONE;
ANTIDIABETIC AGENT;
FOLLITROPIN;
INSULIN;
LEPTIN;
LIPID;
LUTEINIZING HORMONE;
NEUROPEPTIDE Y;
ROSIGLITAZONE;
TESTOSTERONE;
THIAZOLE DERIVATIVE;
ADULT;
ARTICLE;
BLOOD;
BODY WEIGHT;
CLINICAL TRIAL;
DRUG EFFECT;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERANDROGENISM;
INSULIN RESISTANCE;
MENSTRUATION;
METABOLISM;
ORAL DRUG ADMINISTRATION;
OVARY POLYCYSTIC DISEASE;
OVULATION;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
ANDROSTENEDIONE;
BLOOD GLUCOSE;
BODY WEIGHT;
FEMALE;
FOLLICLE STIMULATING HORMONE;
HUMANS;
HYPERANDROGENISM;
HYPOGLYCEMIC AGENTS;
INSULIN;
INSULIN RESISTANCE;
LEPTIN;
LIPIDS;
LUTEINIZING HORMONE;
MENSTRUATION;
NEUROPEPTIDE Y;
OVULATION;
POLYCYSTIC OVARY SYNDROME;
TESTOSTERONE;
THIAZOLES;
THIAZOLIDINEDIONES;
TREATMENT OUTCOME;
|
|
EID: 0036560671
PISSN: 0529567X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (26)
|
|
References (0)
|
